Decentralized Clinical Trials
Transforming care for immunocompromised patients
PPD’s decentralized clinical trial and care models do far more than simplify clinical development for pharmaceutical innovators. They transform lives for immunocompromised patients who no longer have to put their health at risk to receive the care they need. Sara Ashenfelter, a member of PPD’s process optimization team, has experienced the benefits firsthand following a series of rare disease diagnoses. Hear her story.
Choosing Decentralized Clinical Trials
As the clinical landscape continues to evolve, the use of DCT solutions increases, keeping research moving forward and ensuring safety of clinical trials and patients.
DCT Therapeutic Expertise
Our therapeutic expertise spans the full research and development spectrum of indications, including rare disease, hematology/oncology and women’s health.
Why PPD Digital and Decentralized Solutions
PPD expertise supports every stage of the drug development process, helping you pivot to a digital-based trial approach.
“We offer a unique set of flexible solutions across the entire digital and decentralized trial spectrum. All of which are carefully designed to increase patient access to clinical trials and achieve a wide set of benefits from increase patient diversity and patient experience to enhancements in data quality and cost efficiencies for our customers.”
Digital Innovation & Implementation
How can PPD Digital help you reach more patients?